Obesity

Adiposity indicators exhibit depot‐ and sex‐specific associations with multimorbidity onset: A cohort study of the UK Biobank

Diabetes Obes MetabPublished Prospective cohort study

Authors' conclusion

Adiposity indicators are predictors of multimorbidity and comorbidity pairs and represent a promising approach for intervention.

Study context

Population
Adults without multimorbidity (≥2 chronic diseases) at baseline, UK Biobank
Participants
382,678 adults
Exposure
Adiposity indicators and incident multimorbidity
Outcome
Incident multimorbidity
Methodological detailspopulation-based, UK Biobank
  • Population-based
  • UK Biobank

Main finding

As reported in the abstract

Risk increase per one-unit increase in BMI
5.2% (95% CI 5.0%-5.4%)
Risk increase per 0.1 increment in waist-to-height ratio
42.0% (37.9%-46.2%)
Risk increase per 0.1 increment in WHR
27.9% (25.7%-30.0%)
Increased risk with central obesity (waist circumference)
23.2%
Risk increase with body fat percentage, all adults
3% (0.2%-5.9%)
Risk increase with arm fat percentage, all adults
5.3% (0.8%-9.9%)

Observational data: associations, not effects.

Further findings

Incident multimorbidity by sex

Risk increase with body fat percentage, females
5.3% (1.1%-9.7%)
Risk increase with arm fat percentage, males
19.4% (11.0%-28.5%)
Consistent findings for males and females

Onset of comorbidity pairs

General obesity indices, waist circumference, waist-to-height ratio, WHR and central obesity increased onset of comorbidity pairs; hip circumference and hip-to-height ratio decreased it
Adiposity indicators mainly affect DM-related comorbidity onset in males and hypertensive-related comorbidity onset in females

Original publication

Adiposity indicators exhibit depot‐ and sex‐specific associations with multimorbidity onset: A cohort study of the UK Biobank. Diabetes Obes Metab. Published 30 April 2024. doi:10.1111/dom.15610

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.